VeloClub is CyclingTips’ membership program which brings us closer to our members, and connects likeminded cycling enthusiasts.
by Neal Rogers
July 1, 2017
In today’s Daily News Digest: Boels-Dolmans wins opening team time trial at Giro Rosa; Cycling Anti-Doping Foundation announces anti-doping measures for Tour de France; Quintana: ‘The biggest rival is still Chris Froome’; Cavendish: ‘Sometimes following the right wheel is enough for winning’; Dan Martin: ‘I’m very optimistic about my chances’; Froome extends with Team Sky through 2020; Fuglsang extends with Astana through 2019; Bardet, Latour, Naesen extend with Ag2r La Mondiale through 2020; Trek, Specialized launch new road framesets on eve of Tour de France; Coryn Rivera extends with Team Sunweb through 2021; Wiggins hopes to compete in rowing at 2020 Olympics; Lance Armstrong launches daily Tour de France podcast.
On the eve of the Tour de France, Dimension Data sprinter Mark Cavendish — who has 30 Tour stage wins to his name — spoke about his chances after missing out on crucial racing and training due to mononucleosis.
“I managed to train and I tested myself at the Tour of Slovenia and the British championship,” he said at a team press conference. “All I know is that I won’t get dropped in the neutral zone. I’m realistic. I don’t know what my real level is. But I know that we can always be lucky in the sprints. It’s not always necessary to have the best train. Sometimes following the right wheel is enough for winning.”
Ten years ago, Cavendish made his Tour debut in London. He didn’t win any stages that year, but other than 2014, when crashed on stage 1 to Harrogate, he’s won at least one stage at every Tour he’s started. He won four stages last year, but his chances are greatly reduced coming off of illness.
“It’s beautiful to be here,” Cavendish said. “I don’t know what to expect but with a bit of luck, there can be surprises in sprinting. We have a nice team with Dimension Data. Stephen Cummings will be our leader for these three weeks.”